content: SECURITIES AND EXCHANGE COMMISSION
  
  	Washington, D.C.  20549
  
  
  
  	FORM 8-K
  
  	CURRENT REPORT
  
  
  
  	Pursuant to Section 13 or 15(d) of
  	the Securities Exchange Act of 1934
  
  
  	               December 7, 1999
  	Date of Report (Date of earliest event reported)
  
  
  
  	                  MESA LABORATORIES, INC.
  	(Exact name of registrant as specified in its charter)
  
  
        Colorado              	           0-11740          84-0872291
  (State or other jurisdiction	(Commission File Number)	(IRS Employer
  of incorporation)                                   	Identification No.)
  
  
  
  	    12100 West 6th Avenue, Lakewood, Colorado  80228
  	(Address of principal executive offices, including zip code)
  
  
  	                         (303) 987-8000
  	(Registrant's telephone number, including area code)
  
  
  	                                     n/a
  
  	(Former name or former address, if changed since last report)
  
  ITEM 2.  ACQUISITION OR DISPOSITION OF ASSETS.
  
  	(a)	On December 7, 1999, Mesa Laboratories, Inc. (the
  "Registrant") purchased all of the issued and outstanding capital
  stock of Automata Instrumentation, Inc., an Arizona corporation
  ("Automata") from Linda V. Masano and Thomas Michael Masano (the
  "Masanos") pursuant to a Stock Purchase Agreement between Linda V.
  Masano and Thomas Michael Masano (as Sellers) and Mesa
  Laboratories, Inc., a Colorado corporation (as Purchaser) dated as
  of December 7, 1999.  The nature and amount of consideration paid
  by the Registrant was $4,100,000 cash and 100,000 unregistered
  shares of the Registrant's common stock.  The purchase has been
  accounted for under the purchase method of accounting.  There is
  no material relationship between Automata and the Masanos, on the
  one hand, and the Registrant or any of its affiliates, any
  director or officer of the Registrant, or any associate of any
  such director or officer, on the other hand.  The source of the
  funds used in the acquisition was the Registrant's working
  capital.
  
  	(b)	The nature of Automata's business is primarily the
  development, manufacture and marketing of kidney dialysis devices.
   The Registrant intends to continue and expand such business.
  
  ITEM 7.  FINANCIAL STATEMENTS AND EXHIBITS.
  
  	(a)	Financial statements of businesses acquired.  It is
  impracticable to provide the required financial statements at the
  time this Report on Form 8-K is filed.  Accordingly, the
  Registrant is filing herewith such of the required financial
  statements as are available.  The Registrant believes that the
  required financial statements will be available no later than
  February 18, 2000.  The Registrant undertakes to file the required
  financial statements under cover of Form 8 as soon as practicable
  (but not later than 60 days after this Report on Form 8-K must be
  filed).
  
  	(b)	Pro forma financial information. It is impracticable to
  provide the required financial statements at the time this Report
  on Form 8-K is filed.  Accordingly, the Registrant is filing
  herewith such of the required financial statements as are
  available.  The Registrant believes that the required financial
  statements will be available no later than February 18, 2000.  The
  Registrant undertakes to file the required financial statements
  under cover of Form 8 as soon as practicable (but not later than
  60 days after this Report on Form 8-K must be filed).
  
  	(c)	Exhibits.
  
  		(i)	Stock Purchase Agreement Between Linda V. Masano
  and Thomas Michael Masano (as Sellers) and Mesa
  Laboratories, Inc. (as Purchaser) dated as of
  December 7, 1999.
  
  
  
  	SIGNATURES
  
  
  
  	Pursuant to the requirements of the Securities Exchange Act
  of 1934, the Registrant has duly caused this report to be signed
  on its behalf by the undersigned hereunto duly authorized.
  
  
  
  
  						       MESA LABORATORIES, INC.
  
  						           (Registrant)
  
  
  
  
  Date:  December 21, 1999
  	By:________________________________
  						    Luke R. Schmieder, President and
  						    Director
metadata_documents: [{"type": "8-K", "sequence": "1", "secsgml_size_bytes": 3907}]
metadata_filer: {"company-data": {"conformed-name": "MESA LABORATORIES INC /CO", "cik": "0000724004", "assigned-sic": "3823", "irs-number": "840872291", "state-of-incorporation": "CO", "fiscal-year-end": "0331"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-11740", "film-number": "99778617"}, "business-address": {"street1": "12100 W 6TH AVE", "city": "LAKEWOOD", "state": "CO", "zip": "80228", "phone": "3039878000"}, "mail-address": {"street1": "12100 W 6TH AVE", "city": "LUKEWOOD", "state": "CO", "zip": "80228"}}
text: SECURITIES AND EXCHANGE COMMISSION
  
  	Washington, D.C.  20549
  
  	FORM 8-K
  
  	CURRENT REPORT
  
  	Pursuant to Section 13 or 15(d) of
  	the Securities Exchange Act of 1934
  
  	               December 7, 1999
  	Date of Report (Date of earliest event reported)
  
  	                  MESA LABORATORIES, INC.
  	(Exact name of registrant as specified in its charter)
  
        Colorado              	           0-11740          84-0872291
  (State or other jurisdiction	(Commission File Number)	(IRS Employer
  of incorporation)                                   	Identification No.)
  
  	    12100 West 6th Avenue, Lakewood, Colorado  80228
  	(Address of principal executive offices, including zip code)
  
  	                         (303) 987-8000
  	(Registrant's telephone number, including area code)
  
  	                                     n/a
  
  	(Former name or former address, if changed since last report)
  
  ITEM 2.  ACQUISITION OR DISPOSITION OF ASSETS.
  
  	(a)	On December 7, 1999, Mesa Laboratories, Inc. (the
  "Registrant") purchased all of the issued and outstanding capital
  stock of Automata Instrumentation, Inc., an Arizona corporation
  ("Automata") from Linda V. Masano and Thomas Michael Masano (the
  "Masanos") pursuant to a Stock Purchase Agreement between Linda V.
  Masano and Thomas Michael Masano (as Sellers) and Mesa
  Laboratories, Inc., a Colorado corporation (as Purchaser) dated as
  of December 7, 1999.  The nature and amount of consideration paid
  by the Registrant was $4,100,000 cash and 100,000 unregistered
  shares of the Registrant's common stock.  The purchase has been
  accounted for under the purchase method of accounting.  There is
  no material relationship between Automata and the Masanos, on the
  one hand, and the Registrant or any of its affiliates, any
  director or officer of the Registrant, or any associate of any
  such director or officer, on the other hand.  The source of the
  funds used in the acquisition was the Registrant's working
  capital.
  
  	(b)	The nature of Automata's business is primarily the
  development, manufacture and marketing of kidney dialysis devices.
   The Registrant intends to continue and expand such business.
  
  ITEM 7.  FINANCIAL STATEMENTS AND EXHIBITS.
  
  	(a)	Financial statements of businesses acquired.  It is
  impracticable to provide the required financial statements at the
  time this Report on Form 8-K is filed.  Accordingly, the
  Registrant is filing herewith such of the required financial
  statements as are available.  The Registrant believes that the
  required financial statements will be available no later than
  February 18, 2000.  The Registrant undertakes to file the required
  financial statements under cover of Form 8 as soon as practicable
  (but not later than 60 days after this Report on Form 8-K must be
  filed).
  
  	(b)	Pro forma financial information. It is impracticable to
  provide the required financial statements at the time this Report
  on Form 8-K is filed.  Accordingly, the Registrant is filing
  herewith such of the required financial statements as are
  available.  The Registrant believes that the required financial
  statements will be available no later than February 18, 2000.  The
  Registrant undertakes to file the required financial statements
  under cover of Form 8 as soon as practicable (but not later than
  60 days after this Report on Form 8-K must be filed).
  
  	(c)	Exhibits.
  
  		(i)	Stock Purchase Agreement Between Linda V. Masano
  and Thomas Michael Masano (as Sellers) and Mesa
  Laboratories, Inc. (as Purchaser) dated as of
  December 7, 1999.
  
  	SIGNATURES
  
  	Pursuant to the requirements of the Securities Exchange Act
  of 1934, the Registrant has duly caused this report to be signed
  on its behalf by the undersigned hereunto duly authorized.
  
  						       MESA LABORATORIES, INC.
  
  						           (Registrant)
  
  Date:  December 21, 1999
  	By:________________________________
  						    Luke R. Schmieder, President and
  						    Director